Litt, John http://orcid.org/0000-0002-3103-0064
Cunningham, Anthony L. http://orcid.org/0000-0002-6744-5667
Arnalich-Montiel, Francisco http://orcid.org/0000-0002-1229-2018
Parikh, Raunak http://orcid.org/0000-0002-8412-307X
Funding for this research was provided by:
GSK Biologicals SA
Article History
Received: 17 January 2024
Accepted: 3 May 2024
First Online: 4 June 2024
Declarations
:
: John Litt has received payment and/or honoraria from GSK, Merck, Pfizer, Sanofi, and Seqirus, and served as a member of the Immunisation Coalition Scientific Advisory Committee. Anthony L. Cunningham’s institution has received payment and/or honoraria from AbbVie, Curevo, GSK, HealthEd, Merck, Moderna, and Seqirus. Francisco Arnalich-Montiel has no conflicts of interest to disclose. Raunak Parikh is an employee of GSK and holds stock or stock options.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.